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Abstract The stearoyl-CoA desaturase 1 (SCD1) catalyzes
the synthesis of monounsaturated fatty acids. This enzyme
is a critical control point regulating hepatic lipogenesis and
lipid oxidation. Therefore SCD1 may be a potential
therapeutic target in the treatment of obesity and metabolic
syndrome. Regulation of SCD1 expression occurs primarily
at the level of transcription. In the present study, we
characterized the insulin response elements (IREs) and the
insulin signaling pathway mediating the regulation of
SCD1 gene transcription in liver. In chicken embryo
hepatocytes (CEH) and HepG2 cells, insulin stimulates
SCD1 promoter activity by 2.5 folds. This activation is
mediated by two different IREs on the chicken promoter,
one localized between −1,975 and −1,610 bp and one
between −372 and −297 bp. The latter binds both NF-Yand
SREBP-1 transcription factors in response to insulin. We also
demonstrated that insulin induction of SCD1 gene expression
and promoter activity is abolished by pre-incubation of cells
with specific inhibitors of both PI3-kinase (LY294002) and
mTor (Rapamycin) or by over-expression of a dominant
negative mutant of PI3-kinase. The PI3-kinase and mTor
pathway mediates the insulin response on both IREs. In
summary, insulin activates SCD1 gene expression in liver via
a signaling pathway that involves PI3-kinase and mTor and
the downstream transcription factors NF-Y and SREBP-1.
Sentence summary: Insulin regulates SCD1 gene expression
via two different IREs. The most 3′ IRE is localized between
−372 and −297 bp and binds the NF-Y and SREBP-1
transcription factors in response to insulin. PI3-kinase and
mTor mediate the action of insulin on both IREs.




CEH Chick embryo hepatocytes
DEPC Diethyl pyrocarbonate
EMSA Electrophoretic mobility shift assay
FAS Fatty acid synthase
IRE Insulin response element
MAPK Mitogen activated kinase
mTOR Mammalian target of rapamycin
NF-Y Nuclear factor Y
PI Propidium iodide
PY Phospho-tyrosine
qPCR Quantitative polymerase chain reaction
RSV Rous sarcoma virus
SCD1 Stearoyl CoA desaturase 1
SRE Sterol response element
SREBP-1 Sterol response element binding protein 1
SV40 Simian virus 40
Introduction
The stearoyl CoA Desaturase (SCD1) (EC 1.14.99.5) is a
key enzyme involved in the synthesis of monounsaturated
fatty acids. It catalyzes the introduction of a cis double
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bound in Δ9 position of de novo synthesized fatty acids
mainly from palmitoyl- and stearoyl-CoA (Enoch et al.
1976; Kasturi and Joshi 1982). Its regulation is of
physiological importance because changes in the enzyme
activity will lead to changes in cell membrane fluidity
leading to various metabolic diseases such as obesity and
cancers (Ntambi 1995).
In liver, under a standard diet, SCD1 mRNA is weakly
expressed while fat-free high carbohydrate diet dramatically
increased it (Kaestner et al. 1989; Mihara 1990; Ntambi
1995; Thiede and Strittmatter 1985). This regulation is
mainly attributed to a modulation of gene transcription
(Ntambi 1992). It was demonstrated that in human (Bene
et al. 2001; Zhang et al. 2001), chicken (Lefevre et al.
2001) and rodent (Enser 1979; Legrand and Bensadoun
1991; Ntambi 1999), SCD1 genes are under the positive
control of insulin. The effect of insulin on SCD1 appears to
be largely mediated by SREBP-1c (Shimomura et al. 1998)
however a direct binding of SREBP-1 on the SCD1
promoter has never been clearly associated to an insulin
response (Tabor et al. 1998, 1999; Waters et al. 1997). In
chicken LMH hepatoma cells, it was showed that insulin
stimulates SCD1 gene expression through an Insulin
Response Element (IRE) localized in the first 372 pb of
the chicken promoter (Lefevre et al. 2001).
Insulin controls gene transcription by modifying the
binding of transcription factors on IREs or by regulating
their transcriptional activities (Mounier and Posner 2006).
Several IREs have been defined through which insulin up-
regulates gene transcription. Among them, the sterol
response element binds the transcription factors of the
SREBP family, particularly SREBP-1c (Eberle et al. 2004).
A binding of activator protein 1 (AP-1) has also been
identified in the promoter regions of several genes up-
regulated by insulin. A large number of insulin responsive
genes also harbour a new type of IRE containing GC-rich
regions which binds the ubiquitous transcription factor Sp1
(Samson and Wong 2002).
The binding of insulin to the insulin receptor tyrosine
kinase (IRK) is followed by IRK autophosphorylation,
activation, and the phosphorylation of IRSs on tyrosine
residues. These phospho-tyrosine motifs bind adaptor pro-
teins, such as the p85 regulatory subunit of PI3-kinase. (Alessi
and Downes 1998; Yenush et al. 1998). Observations
indicate that the activation of PI3-kinase is a major route
through which insulin modulates gene transcription (Band
and Posner 1997; Dickens et al. 1998; Sutherland et al. 1995,
1998). Several pathways have been implicated downstream
of PI3-kinase such as the activation of Akt (Agati et al. 1998;
Liao et al. 1998; Schmoll et al. 2000) which directly
phosphorylates the transcription factors Foxo-1, HNF-3β
and CREB (Brunet et al. 1999; Chakravarty et al. 2005; Ogg
et al. 1997). We and others have also clearly identified a role
for mTor, downstream of PI3-kinase, in mediating insulin
effect on IGFBP-1 gene transcription (Band and Posner
1997; Mounier et al. 2006; Patel et al. 2002). Independently
of PI3-kinase, insulin can also mediate its effect on gene
expression through the activation of the MAPK pathway
(Ayala et al. 2004; Keeton et al. 2003; Kotzka et al. 2004;
Nadeau et al. 2004).
In the present study we showed, that in chick embryo
hepatocytes in culture (CEH) and in HepG2 cells, insulin
up-regulates SCD1 gene expression. The insulin action was
mediated by 2 different IREs on the chicken promoter, one
localized between −1,975 and −1,610 bp upstream of the
CAP site and one between −372 bp and −297 bp. The most
3′ element recruited the NF-Y and SREBP-1 transcription
factors in response to insulin. In addition, we demonstrated
that upon insulin treatment of both CEH and HepG2 cells a
PI3-kinase and mTor dependent pathway was activated
mediating the insulin effect on chicken and human SCD1
promoters. Finally, we showed that this insulin-activated




Leghorn chickens were obtained from Couvoir Simentin
(Mirabel, Canada). LY294002 and Rapamycin were from
Calbiochem (EMD Biosciences, San Diego, CA). The
GAPDH, Akt, anti-phospho-Akt (ser273), p70S6-kinase
and anti-phospho-p70S6-kinase (Thr 389) antibodies were
from Cell Signaling Technology, Inc. (Danvers, MA). The
Tyr(P) (PY99), SREBP-1 and NF-Y antibodies were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA).
The PI3-kinase p85 and IRS1 antibodies were from Upstate
Biotechnology, Inc. (Lake Placid, NY). The rat SCD1
antibody was a generous gift of Dr. J. Ozols (Farmington,
CT). Protein A-Sepharose was from Amersham Biosciences
Inc. (Baie d’Urfé, Canada). The collagenase H and the
Fugene-HD reagent were purchased from Roche Diag-
nostics (Laval, Canada). The Waymouth medium MD
705/1, MEM and the porcine insulin were obtained from
Sigma. Lipofectin reagent was from Invitrogen Canada
Inc. (Burlington, Canada). The 6 wells-cell + culture
plates were purchased from Sarstedt (St. Laurent,
Canada) and luciferase reagent from Promega (Madison
WI). ATP was purchased from PerkinElmer Life Sciences
(Wellesley, MA). The human SCD1 promoter construct
was kindly provided by Drs S.M. Prouty and W. Samuels
(NIH, Bethesda, MD). Most other reagents and chemicals
were obtained from Sigma and were of the highest grade
available.
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Plasmid constructions
The SCD1-1 to the SCD1-6 DNA constructs were a
generous gift of Dr. C. Diot (Lefevre et al. 2001). pGL2-
Basic Vector and pGL2-Promoter Vector were used as
negative and positive controls respectively (Promega,
Ontario, Canada). The SCD1-7 promoter construct was
generated by deleting a 75 bp fragment (−372 to −297 bp)
from the SCD1-6 plasmid using the NruI and SmaI
restriction enzymes (New England Biolabs, Ipswich, MA).
The RSV β−galactosidase plasmid (pRSV-βGal) was used
to evaluate transfection efficiency (Baillie et al. 1993). The
dominant negative PI3-kinase construct (Δp85) contains a
cDNA encoding the p85 regulatory subunit, whose p110
binding region was deleted (Kong et al. 2000). The 2156 bp
of the avian SCD1 promoter sequence was published in
Genbank under the number DQ645535.
Cell culture and transfection procedure
Chick embryo hepatocytes (CEH) were isolated from livers
of 19-day-old chick embryos (Goodridge 1973) (protocol
no. 500 approved by the University animal care comity).
2.5×106 cells were plated in 6-wells-cell + culture plates
and cultured at 40°C under 5% CO2 in serum-free
Waymouth medium MD 705/1 containing streptomycin
(100 μg/ml) and penicillin G (60 μg/ml). After 6 h, cells
were transfected with either 1.5 μg of the SCD1–1
construct or 1.5 μg of the constructs containing the
different SCD1 5′ deletions and 0.5 μg of pRSV-βGal
(Baillie et al. 1993). Briefly, cells were incubated with the
DNA/Lipofectin mixture for 16–24 h. Thereafter, the
medium was replaced with fresh medium with or without
addition of 50 nM insulin and the incubation was continued
for an additional 24 h. For the experiences implicating the
use of kinases inhibitors, CEH were stimulated 24 h with
50 nM insulin after 30 min of preincubation with either
vehicle (DMSO 0,5%), 50 μM LY294002 or 200 nM
Rapamycin. The HepG2 cells were used to test the
activity of the human SCD1 promoter. Cells were
cultured in MEM media containing 4 mM glutamine
and transfected with DNA constructs using Fugene HD
(Roche Diagnostics) as previously described (Fillion-
Forté and Mounier 2007). HepG2 cells were also used to
overexpress the dominant negative p85. Cells were trans-
fected with 1.5 μg of the Δp85 construct and in presence
or not of either 1.5 μg of the SCD1–1 construct or the
pBluescript vector (Kong et al. 2000). After 24 h, the
medium was changed to a medium containing 50 nM of
insulin for an additional 24 h.
Effects of kinases inhibitors on CEH viability were
evaluated by flow-cytometry with PI staining using
FACScan (Sakurai et al. 1999).
Analysis of cell extract
CEH and HepG2 cells were lysed at room temperature in
500 μl of CAT Elisa lysis buffer (Roche Diagnostics, Laval,
Canada) and protein concentration (Bradford 1976), lucif-
erase (de Wet et al. 1987) and β-galactosidase (Sambrook
and Russell 2000) activities were measured by the indicated
methods. The results were expressed as luciferase activity
per milligram of soluble protein and then normalized for
transfection efficiency using the β-galactosidase activity.
Transcriptional rates were expressed as a percentage of the
standardized activity measured in the untreated cells.
Gel electrophoretic mobility shift assay
Nuclear extracts were prepared from HepG2 cells incubated
for 24 h with 100 nM insulin (Andrews and Faller 1991).
Double-stranded oligonucleotides were labelled with
[γ-32P]ATP using the T4 polynucleotide kinase. 6 μg of
nuclear proteins were mixed with 12 μl of binding buffer
containing 20,000 cpm of 32P-labeled probe, 2 μg of poly
(dI-dC), 0.01% Nonidet P-40, 0.8 μg of bovine serum
albumin, 5% (v/v) glycerol, and 5 μg of salmon sperm
DNA. The reaction was incubated for 15 min at room
temperature. Competition experiments were performed using
a molar excess of unlabelled wild-type oligonucleotide. The
sequence of the mutated probes 1 and 2 were respectively:
GCGAACCATCACAGACGGCAGCTTCGAGGCAGG;
TCCCGCAGTTCGACGGCTCG. Antibody experiments
used the same incubation conditions except that 2 μl of
either SREBP-1 or NF-Y antibodies (2 μg) were incubated
with the reaction mixture for an additional 15 min at room
temperature. The reaction mixtures were then subjected to
electrophoresis on a 6% polyacrylamide gel at 150 V in
25 mM Tris-HCl, 0.19 M glycine, 1 mM EDTA. Gels were
dried and visualized by autoradiography using the phospho-
imager system (Molecular imager FX, Biorad, Mississauga,
Canada).
Western blot analysis
After treatment with the test agents for the time and the
concentration indicated in the figure legends, CEH or
HepG2 cells were rinsed twice with ice-cold phosphate-
buffered saline (pH 7.4) and solubilized with lysis buffer
(50 mM Hepes, pH 7.5, 150 mM NaCl, 10 mM sodium
pyrophosphate, 100 mM sodium fluoride, 1.5 mM MgCl2,
1 mM EGTA, 200 μM sodium orthovanadate, 1 mM
phenylmethylsulfonyl fluoride, 10 μg/ml leupeptin, 10 μg/
ml aprotinin, 10% glycerol, and 1% Triton X-100). Cell
lysates were clarified by centrifugation at 10,000×g for
20 min at 4°C, and protein concentrations in the resulting
supernatants were determined using the BioRad protein
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assay (BioRad, Mississauga, Canada). Twenty micrograms
of proteins from cell lysates were mixed with 4 μl of 3×
Laemmli sample buffer (2% SDS, 2% β-mercaptoethanol,
10% V/V glycerol and 50 mg/l bromophenol blue in 0.1 M
Tris-HCl buffer, pH 6.8), heated at 100°C for 5 min,
subjected to SDS–PAGE and then transferred to Immobi-
lon-P membranes for immunoblotting. Membranes were
incubated for 1 h in blocking buffer (1X TBS, 0,1% Tween-
20: TBST) containing 5% BSA and then overnight in the
same buffer with addition of antibodies raised against,
SCD1 (1/6,000), GAPDH (1/2,500), PI3-kinase p85 (1/
4,000), Akt (1/2,000), phospho-Akt (1/2,000), p70-S6
kinase (1/1,000), phospho-p70-S6 kinase (1:1,000) or
IRS-1 (1/2,000). After three successive washes in 1X
TBST, membranes were incubated for 1 h at room
temperature in 1X TBS in presence of an anti Rabbit IgG
binds to the horseradish peroxidase (1:2,000). Signals were
revealed using the ECL plus Western blotting detection
reagent according to the manufacturer instructions (GE
Healthcare, Baie d’Urfé, Canada). The appropriate bands
were quantified using the phospho-imager system (Molec-
ular imager FX, Biorad, Mississauga, Canada).
PI3-kinase activity assay
Lysates (300 μg of protein) from insulin-treated (100 nM
insulin for 5 min) or non-treated HepG2 cells over-expressing
or not the dominant negative p85, were immunoprecipitated in
the presence of protein A-Sepharose, using a specific an anti-
phosphotyrosine antibody. Immunoprecipitates were exten-
sively washed, and the protein A-Sepharose pellets were
resuspended in 50 μl of kinase assay buffer (20 mMTris-HCl,
pH 7.5, 100 mMNaCl, 0.5 mM EGTA) containing 0.5 mg/ml
L-α-phosphatidylinositol (Avanti Polar Lipids, Inc., Alabas-
ter, AL) and assayed for PI3-kinase activity as described
previously (Band and Posner 1997).
RNA analysis
Total RNA was extracted from CEH as previously
described (Chomczynski and Sacchi 1987), UV-quantified
and diluted in 15 μl of DEPC-treated water at a
concentration of 1 μg/μl. Reverse transcription (RT) was
performed using the Omniscript enzyme kit of Qiagen
(Montreal, Canada) and Oligo-dT (Roche Diagnostics,
Laval, Canada) for 1 h at 37°C with an inactivation step
at 93°C during 5 min. qPCRs were performed using the
QuantiTect SYBR Green PCR Kit from Qiagen (Montreal,
Canada) and the LightCycler device (Roche Diagnostics,
Laval, Canada). The reactions were realized with 10% of
the cDNA and 0.5 μM of both forward and reverse
specifics primers for 50 cycles to ensure exponential
amplification phase. The HPRT-1 gene was used as
reference. The relative quantification was then performed
using the RelQuant software (Roche Diagnostics, Laval,
Canada). For the SCD1 gene, primers were defined on
avian sequences: GCCTTCCAGAATGACATCTATG
(sense) and AAATCACTCAGGTCCAGCTTC (antisense)




Insulin stimulates the avian SCD1 promoter activity
in chick embryo hepatocytes (CEH)
Previous studies have demonstrated that insulin stimulates
SCD1 gene expression in various species. However, the
molecular mechanism underlying insulin action remains to
be delineated. In the present study, we have used the chick
embryo hepatocytes transfected with the avian promoter to
characterize this response. The choice of this model was
justified by the fact that in birds like in human, lipogenesis is
mainly hepatic. In addition this primary cell culture model
has been extensively used to study lipogenic gene expression
and was therefore well characterized (Hillgartner et al.
1995). As described under “Materials and methods”, cells
were transiently transfected with luciferase promoter con-
structs (SCD1-1 to SCD1-6, Fig. 1a containing different 5′
flanking regions of the chicken SCD1 gene promoter
(Lefevre et al. 2001). All the constructs presented a high
level of luciferase activity compared to the SV40 promoter
(left panel, C). When the fragment localized between
−1,975 and −1,610 bp was deleted, a significant decrease
in the basal SCD1 promoter activity was observed suggest-
ing the presence of a positive transcriptional element in this
region.
We subsequently evaluated the effect of insulin on the
SCD1 promoter activity. As shown in Fig. 1a, insulin
increased SCD1-1 luciferase activity by about 2.5 folds.
However, insulin activated SCD1 mRNA and protein levels
by more than 5 folds (Figs. 1b, 5a and b). This suggested that
additional 5′ sequences may be required to mediate the full
insulin action or that insulin acted at a post-transcriptional
level. In order to localize the insulin response element(s)
(IREs), we subsequently tested the effect of insulin on various
5′ deletions. Deletion of the −1,975 and −1,610 fragment
decreased the effect of insulin to 1.5 fold. A similar level of
activation is measured when cells were transfected with all
the other SCD1 constructs (viz. SCD1–3 to SCD1–6). These
experiments suggested that at least two different IREs
mediate the action of insulin on the SCD1 promoter, one
element localized between −1,975 and −1,610 bp and a
second in the first 372 bp of the avian promoter.
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Characterization of the most 3′ IRE
We next focused on the IRE localized on the SCD1–6
construct. This 372 bp fragment contains several consensus
binding sites for transcription factors required for insulin-
mediated activation of transcription in other genes (Fig. 2a)
(Mounier and Posner 2006). To demonstrate DNA-binding
of nuclear factor(s) to the putative cis-element(s) previously
identified, EMSA experiments were conducted using 32P-
labeled double-stranded oligonucleotides corresponding to
different parts of the 372 bp sequence (probes 1–4, Fig. 2a).
When radiolabeled probes were incubated with nuclear
extracts prepared from insulin-stimulated HepG2 cells,
DNA-protein complexes were observed only with the
probes 1 and 2 (Fig. 2b). The specificity of DNA binding
on probes 1 and 2 was confirmed by competition with
increasing concentration of non-radioactive probes. Finally,
we performed EMSAwith mutated probes 1 and 2 and have
showed that the DNA binding of insulin-treated nuclear
extracts was strongly inhibited (Fig. 2c).
In order to identify the trans-acting factors involved in
the insulin-activation of SCD1 gene expression, supershift
EMSA experiments were conducted using antibodies raised
against the known transcription factors binding to the serum
response element (SRE) and the NF-Y motifs (SREBP-1
and NF-Y). The retarded band observed with probe 1 and
insulin-treated nuclear extracts, disappeared in presence of
either SREBP-1 or NF-Y antibody while with probe 2, the
retarded band disappeared only in presence of the NF-Y
antibody (Fig. 2d). This indicated that both SREBP-1 and
NF-Y transcription factors were recruited on the SCD1
promoter upon insulin treatment of the cells.
The functionality of this region was subsequently
validated by transfection experiments in hepatic cells.
Deletion of the SRE like and NF-Y motifs (SCD1–7,
Fig. 3a) totally abolished the insulin effect on the SCD1
promoter activity (Fig. 3b). When combined, these data
suggested that the −372 to −297 bp fragment of the chicken
SCD1 promoter contains an IRE that binds SREBP-1 and
NF-Y transcription factors in response to insulin.
Role of PI3-kinase and mTor on the insulin-induced SCD1
gene transcription
We next characterized the signaling pathway mediating the
insulin effect on the SCD1 promoter. As described under
“Materials and methods,” CEH were pre-treated for 30 min
with specific inhibitor of either PI3-kinase (50 μM
LY294002) or mTor (200 nM rapamycin) and subsequently
stimulated for 10 min with 100 nM insulin. As shown in
Fig. 4a insulin stimulated Akt phosphorylation on the serine
473 residue in CEH. This stimulation was abolished by the
presence of LY290042 while presence of rapamycin had no
effect. The effect of rapamycin was evaluated by measuring
the level of p70-S6 kinase phosphorylation on residue
Thr389 in response to insulin. As shown in Fig. 4b, insulin
stimulated p70-S6 kinase phosphorylation in CEH while
incubation with 200 nM of rapamycin totally abolished the
insulin effect. Presence of either PI3-kinase or mTor
inhibitor did not affected CEH viability in culture as
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Fig. 1 Effect of insulin on cells transfected with constructs containing
different deletions of the 5′-flanking region of the SCD1 gene linked
to luciferase. a Chick embryo hepatocytes were isolated and incubated
in serum free media for 6 h before transfection. Cells were then
transiently transfected using lipofectine (10 μg/plate), SCD1–1
(1.5 μg/plate or an equimolar amount of the other constructs) and
pRSV-βGal (0.5 μg/plate) as described under “Materials and
methods”. After removing the transfection medium, the hepatocytes
were incubated for an additional 24 h in either serum-free Waymouth
medium (white bars) or in the same medium containing 100 nM
insulin (black bars)—Left section, reporter gene DNA constructs used
in this experiment. The number at the left of each construct indicates
the 5′-end of the fragment in nucleotides relative to the major start site
for transcription. +1 indicates the site of initiation of transcription. For
all constructs, the 3′-end is at +125 bp. O: pGL2 basic vector (negative
control); C: pGL2 basic vector containing the SV40 early promoter
(positive control). Right section, values represented luciferase activi-
ties normalized by β-galactosidase activities per milligram of soluble
protein. Luciferase activities are expressed as a percentage of the
activity measured with the SCD1–1 construct in non stimulated cells.
Asterisk p<0.05 comparing non insulin-stimulated activities of SCD1–3,
SCD1–4, SCD1–5 and SCD1–6 versus SCD1–1 and SCD1–2. Section
sign p<0.05 comparing the insulin effect on SCD1–1 versus the insulin
effect on either SCD1–2, SCD1–3, SCD1–4, SCD1–5 or SD1–6.
Results are the means ± S.D. of at least five experiments, each one using
an independent batch of isolated hepatocytes. b HepG2 cells were
treated (+) or not (−) for 10 min with 100 nM insulin. Cells were lysed,
and extracted proteins were resolved on SDS–PAGE and immunoblot-
ted with either an anti-SCD1 antibody (top panel) or an anti-GAPDH
antibody (bottom panel)
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The effects of both inhibitors were subsequently evalu-
ated on the insulin-induced SCD1 gene expression. Pre-
incubation of CEH with LY294002 totally prevented the
effect of insulin on SCD1 mRNA expression (Fig. 5a while
presence of rapamycin inhibited it by more than 50%
(Fig. 5b). In order to validate our observations at the
transcriptional level, the SCD1–1 construct which contains
the two IREs and the SCD1–6 construct which contains the
most 3′ element were transfected in CEH. LY294002 and
rapamycin also abolished the insulin effect on both SCD1–1
and SCD1–6 transcriptional activity (Fig. 5c and d
respectively). Taken together, our data suggested that both
PI3-kinase and mTor mediated the insulin action of the
SCD1 gene expression. The total abolition of the insulin
effect on transcription in presence of one of these inhibitors
probably indicated that both kinases worked on the same
pathway.
In order to confirm the role of PI3-kinase in mediating
the effect of insulin on SCD1 gene expression, we have co-
transfected the SCD1–1 plasmid with a dominant negative
(DN) mutant of PI3-kinase (Δp85) (Kong et al. 2000) in
the human hepatocarcinoma cell line HepG2. This cell line
was used instead of CEH in order to attain a high level of
Δp85 expression. Figure 6a shows that in our experimental
conditions, Δp85 was specifically over-expressed while the
levels of IRS1 and Akt expression, upstream and down-
stream effectors of PI3-kinase respectively, were unaffect-
ed. Over-expression of the Δp85 strongly inhibited the
insulin-induced PI3-kinase activity (Fig. 6b) and Akt
phosphorylation on serine 473 residue (Fig. 6c). Co-
transfection of the Δp85 construct with the SCD1–1
plasmid abolished the insulin effect on the SCD1 promoter
activity (Fig. 6d). In conclusion, the effects of both
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RFig. 2 Analysis of DNA binding activity of the nuclear proteins from
insulin-treated cells on the chicken SCD1 promoter- a Analysis of
DNA binding activity of the nuclear proteins from insulin-treated cells
on the chicken SCD1 promoter- a Sequence of the first 372 bp of the
chicken SCD1 promoter (Genebank no. DQ645535). Consensus
binding sites for transcription factors are indicated in bold. Squares
indicate the different probes used in the EMSA experiments. b 6 μg of
nuclear extracts prepared from untreated (−) or insulin stimulated (+)
HepG2 cells were incubated with 4 different 32P-labeled double-
stranded fragment of the SCD1 promoter (probes 1–4). Competition
with unlabelled probe was performed using molar excess of the
double-stranded probe 1 or probe 2. Putative binding sites for
transcription factors are indicated on the bottom of each gel. The
major DNA-protein complex is designated by the arrow (retarded
band). A representative autoradiography of three separate experiments
is depicted. c 6 μg of nuclear extracts prepared from untreated (−) or
insulin stimulated (+) HepG2 cells were incubated with either a wild
type (WT) or mutated (Mut) 32P-labeled double-stranded probe 1 or 2.
d 6 μg of nuclear extracts prepared from untreated (−) or insulin
stimulated (+) HepG2 cells were incubated with either probe 1 or 2.
IgGs (1 μg each) were added after mixing labelled probe and nuclear
extract; they were anti-SREBP-1 (BP-1) or anti-NF-Y (NF-Y).
Putative binding sites for transcription factors characterized in each
probes are indicated. A representative autoradiography of three
separate experiments is depicted
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confirmed the role of PI3-kinase in mediating the insulin
action on the regulation of SCD1 gene expression.
We next evaluated the role of this insulin-signaling
pathway on the human SCD1 promoter. Therefore, the
HepG2 cells were transfected with a luciferase reporter
construct containing about 4 kb of the human SCD1
promoter (kindly provided by Drs Samuel and Prouty,
Bethesda, MD). As demonstrated for the chicken promoter,
insulin stimulated the human SCD1 promoter activity by
about 2 folds (Fig. 7a. Comparison (Fig. 7b) between the
proximal human and chicken promoter sequences revealed
the presence of conserved consensus binding sites for
transcription factors previously identified as mediators of
the insulin effect on the chicken promoter (Figs. 2 and 3).
Presence of both LY20042 and rapamycin also abrogated
the insulin effect on the human SCD1 promoter expression.
In conclusion, our data demonstrated that insulin-
activation of both PI3-kinase and mTor were necessary
and sufficient to mediate the action of insulin on both
chicken and human SCD1 promoters. The abrogation of the
insulin effect on SCD1 gene transcription in presence of
only one of the inhibitor suggested that PI3-kinase and
mTor probably worked on the same signaling pathway. In
addition, our data suggested that at least 2 different IREs
were present on the avian SCD1 promoter. The most 3′ IRE














































Fig. 3 Effect of insulin on cells transfected with a construct lacking
the Insulin Response Element 2. a Schematic representation of SCD1–
6 and SCD1–7 constructs. Consensus binding sites for transcription
factors are indicated. b Chick embryo hepatocytes were transfected
with the SCD1–1, the SCD1–6 or the SCD1–7 construct and treated
(black bars) or not (white bars) with 100 nM insulin as described in
the legend of Fig. 1. Left section, reporter gene DNA constructs used
in this experiment. Right section, bars represented luciferase activities
normalized by β-galactosidase activities per milligram of soluble
protein. Luciferase activities were expressed as a percentage of the
activity measured in the respective non insulin treated sample. *p<
0.05 comparing insulin-treated cells transfected with SCD1–6 versus
insulin-treated cells transfected with SCD1–7. Results are the means ±
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Fig. 4 Effect of LY294002 and rapamycin on insulin responses in chick
embryo hepatocytes. a Chick embryo hepatocytes were treated (+) or
not (−) for 10 min with 100 nM insulin after 30 min of preincubation
with either vehicle (−), 50 μM LY290042 (Ly) or 200 nM rapamycin
(Ra). Cells were lysed, and extracted proteins were resolved on 8%
SDS–PAGE and immunoblotted with either an anti-Akt antibody (lower
panel) or an antibody that recognized the phosphorylated isoform of Akt
(top panel). The autoradiographs are representatives of three different
experiments b Chick embryo hepatocytes were treated (+) or not (−) for
10 min with 100 nM insulin after 30 min of preincubation with 200 nM
rapamycin. Cells were lysed, and extracted proteins were resolved on
SDS–PAGE and immunoblotted with either an anti-p70-S6 kinase
antibody (lower panel) or an antibody that recognized the phosphory-
lated isoform of p70-S6 kinase (top panel). The autoradiographs are
representatives of three different experiments. c Chick embryo
hepatocytes were treated with either 50 μM LY290042 or 200 nM
rapamycin for 30 min. Cell viability was subsequently evaluated by PI
staining using FAScan. Bars represent the percentage of living cells
measured in at least two different wells
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and NF-Y transcription factors in response to insulin.
Finally we also showed that both IRES are targeted by
the insulin-induced PI3-kinase/mTor dependent pathway.
Discussion
In the present study, we have demonstrated that insulin
stimulates SCD1 gene transcription by 2.5 folds in both chick
embryo hepatocytes and HepG2 cells (Figs. 1, 5 and 7).
SCD1 gene transcription is stimulated by insulin to a similar
level in LMH cells (Lefevre et al. 2001) and mouse liver
(Waters and Ntambi 1994) while enzyme activity in cultured
avian liver explants is induced by 4 fold (Joshi and Aranda
1979). In our study, we showed that in hepatic cells, insulin
induced SCD1 mRNA and protein expressions by more than
5 folds (Figs. 1b, 5a and b). This suggested that additional
sequences localized further upstream on the chicken pro-
moter was necessary to mediate the full insulin response on
SCD1 gene expression. It also suggested that insulin acts at a
post-transcriptional level. Taken together, our data suggested
that insulin regulates SCD1 gene expression in liver by
modulating the level of SCD1 gene transcription but also
by influencing the level of the mRNA and protein expression
by a still unknown mechanism.
Using 5′ deletions constructs, we delineated two areas
that mediate the insulin action on the avian SCD1 promoter.
One area is localized between −1,975 and −1,610 bp
(IRE1) and the second element between −372 and −297 bp
(IRE2). A previous study performed in LMH cells had
already suggested the presence of an insulin response
sequence in the same region (viz. −372/+125) (Lefevre
et al. 2001). Analysis of the avian SCD1 promoter sequence
revealed the presence of several consensus binding sites for
Fig. 5 Effect of LY294002 and rapamycin on insulin-induced SCD1
gene expression. a and b Chick embryo hepatocytes were cultured for
24 h with (black bars) or without insulin (white bars). Prior to
incubation with the hormone, cells were treated for 30 min with either
vehicle (0.5% DMSO), 50 μM Ly290042 (Ly) or 200 nM rapamycin
(Ra). Total RNA were subsequently extracted as described under
“Materials and methods” and SCD1 mRNA levels were evaluated by
qPCR using the HPRT-1 gene as standard. Results were expressed as a
percentage of SCD1 mRNA level expressed in basal condition in
absence of inhibitor. Bars indicate standard deviation (S.D.). Section
sign p<0.05 inhibitor-treated versus non-treated cells. Chick embryo
hepatocytes were transfected with SCD1–1 (C) or SCD1–6 (D) and
treated (black bars) or not (white bars) with insulin as described in the
legend of Fig. 1 with preincubation with either vehicle (0.5% DMSO),
50 μM LY294002 (Ly) or 200 nM rapamycin (Ra). Values represented
luciferase activities normalized by β-galactosidase activity per
milligram of soluble protein. Results were expressed as a percentage
of the activity measured in non-stimulated cells transfected with the
corresponding construct and incubated with vehicle only. They are the
mean of at least three separate experiments; bars indicate standard
deviation (S.D.). Asterisk p<0.05 insulin-treated versus non-treated
cells
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transcription factors known to mediate the insulin action on
gene transcription (Mounier and Posner 2006) (Fig. 8). A
consensus binding site for USF, known to mediate the
positive action of insulin on FAS gene expression (Griffin
and Sul 2004) has been localized in the most 5′ sequences
containing the IRE1. In the same region, a consensus binding
site for SREBP-1, also known to mediate the positive action
of insulin on both Acetyl CoA carboxylase (Magana et al.
1997) and FAS genes expressions (Porstmann et al. 2005)
has been identified.
We characterized the IRE2 on the chicken promoter.
This IRE2 is localized between 372 and −297 bp and binds
SREBP-1 and NF-Y in response to insulin. Deletion of this
DNA region abolished the insulin effect on SCD1 promoter
activity. These transcription factors were previously de-
scribed as positive mediators of insulin action on gene
transcription (for review, (Mounier and Posner 2006)). Of
great interest, the presence of these sites appears to be
conserved between the chicken and human SCD1 pro-
moters (Fig. 7b).
Using a specific pharmaceutical inhibitor for PI3-kinase
as well as a dominant negative construct for p85 (Kong
et al. 2000), we have clearly demonstrated that activation of
PI3-kinase by insulin was necessary and sufficient to
mediate the hormonal effect on the SCD1 promoter activity
(Figs. 5, 6, and 7). A similar implication of PI3-kinase in
mediating the positive action of insulin was previously
described for the FAS, SREBP-1 and glucokinase genes
(Matsumoto et al. 2002; Wang and Sul 1998). In addition,
PI3-kinase was implicated in the insulin down-regulation of
gene expression for the PEPCK, G6Pase and IGFBP-1
genes (Band and Posner 1997; Dickens et al. 1998;
Mounier et al. 2006; Sutherland et al. 1995, 1998). Our
observations are in agreement with the fact that activation
of a PI3-kinase dependent pathway is the major route
through which insulin modulates gene transcription.
Most of the studies looking at downstream PI3-kinase
effectors have implicated Akt as a key mediator of insulin
RFig. 6 Effect of the dominant-negative p85 mutant on PI3- kinase, Akt
and SCD1 promoter activities in response to insulin in HepG2 cells.
HepG2 cells were treated (+) or not (−) for 5 min with 100 nM insulin in
presence (+) or absence (−) ofΔp85 over-expression. a Cells were lysed,
and extracted proteins were resolved on 7% SDS–PAGE then
immunoblotted with either an anti-IRS-1 (top panel), an anti-p85
antibody (middle panel) or and anti-Akt antibody (bottom panel). A
representative autoradiograph is presented. b The HepG2 cell lysates
were immunoprecipitated with αPY antibody and the immunoprecipi-
tates were analyzed for PI3-kinase activity as described under “Materials
and methods”. A representative autoradiograph is presented. PIP3
indicates the product of the PI3-kinase reaction. c Cells were lysed, and
extracted proteins were resolved on SDS–PAGE then immunoblotted
with either an anti-Akt antibody (lower panel) or an antibody that
recognized the phosphorylated isoform of Akt (top panel). A
representative autoradiograph is presented. d HepG2 cells were trans-
fected with either Bluescript (Mock) or with the dominant negative p85
(Δp85) construct in combination with the SCD1–1 construct as
described under “Materials and methods”. After 24 h, medium was
removed and replaced by the same medium in presence (black bars) or
absence (white bars) of 100 nM insulin. Values represented luciferase
activities normalized by β-galactosidase activities per milligram of
soluble protein. Results were expressed as a percentage of the activity
measured in non-stimulated cells transfected with the SCD1–1 construct
and the Bluescript. They are the mean of at least three separate
experiments; bars indicate standard deviation (S.D.)
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action on gene transcription. Activation of Akt mediates the
insulin effect on PEPCK and G6Pase expression (Agati
et al. 1998; Liao et al. 1998; Schmoll et al. 2000) by
directly phosphorylating the transcription factors Foxo-1,
HNF-3β and CREB (Brunet et al. 1999; Chakravarty et al.
2005; Ogg et al. 1997). Akt was also implicated in the
insulin-induced FAS transcription (Wang and Sul 1998). In
our study, we did not excluded a role of the Akt kinase in
mediating the action of insulin on SCD1 gene transcription
but we showed that it probably acted upstream of the kinase
mTor as rapamycin abolished the effect of insulin on SCD1
promoter activity (Figs. 4 and 7).
As mentioned above, our data demonstrated that mTor
mediated the insulin response on both chicken and human
SCD1 gene transcription (Figs. 5 and 7). mTor was
described as a nutrient sensor pathway and associated, like
SCD1 with the development of obesity and several
metabolic diseases (for review (Marshall 2006)). Of great
interest, it was previously showed that PI3-kinase and mTor
mediate the effect of PDGF on SCD1 gene expression in
fibroblasts with evidences for the implication of the
transcription factor SREBP-1 (Demoulin et al. 2004). In
addition, growing evidences implicated the mTor kinase in
modulating expression of several other different genes. We
and others have previously demonstrated that insulin
inhibition of IGFBP-1 gene expression required the
activation of the mTor kinase in liver (Band and Posner
1997; Mounier et al. 2006; Patel et al. 2002). Furthermore,
mTor was implicated in the phosphorylation of the
transcription factors STAT1 and STAT3 leading to activa-
tion of STAT-dependent gene transcription (Kristof et al.
2003). mTor also plays a critical role in adipogenesis by
directly modulating the activity of the transcription factor
PPARγ (Kim and Chen 2004). It was also clearly
established that ribosome biogenesis was controlled at the
level of rDNA transcription by mTor through activation of
the transcription factors UBF and TIF1A (Hannan et al.
2003; Mayer et al. 2004). Finally, as demonstrated by
microarray analyses using rapamycin-treated mammalian
cells, mTor signalling was implicated in the control of
transcription for many genes, particularly those involved in
the metabolic and biosynthetic pathways (Peng et al. 2002).
In agreement with our data, Peng’s study showed that in
rapamycin-treated cells, the level of SCD1 gene expression
Fig. 8 Schematic representation of the regulation of SCD1 gene
transcription in hepatic cells. Schematic representation of the
regulation of SCD1 gene transcription in hepatic cells. The top part
of the figure represents the signaling pathway implicated in the insulin
regulation of SCD1 gene transcription. The large grey arrow
represents the promoter where the different 5′-deletion constructs are
indicated. The lower part represents the transcription factors implicat-
ed in the regulation of SCD1 gene transcription in liver in response to
activation of the indicated signaling pathway
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Fig. 7 Effect of LY294002 and rapamycin on insulin-mediated
activation of the human SCD1 promoter activity in HepG2 cells. a
HepG2 cells were transfected with the human SCD1 promoter
construct and treated (black bars) or not (white bars) with insulin as
described in the legend of Fig. 1. Prior to incubation with the
hormone, cells were treated for 30 min with either vehicle (0.5%
DMSO), 50 μM LY294002 or 200 nM rapamycin. Results are
expressed as previously described in Fig. 5. b Sequence alignment
between the human (AF320307) and chicken SCD1 promoters
(DQ645535). Conserved consensus binding sites for the two key
transcription factors are shaded. SRE: Sterol regulatory element. NF-Y:
Nuclear factor Y
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is inhibited compared to the level measured in non-treated
cells.
The molecular mechanism of mTor action on SCD1 gene
transcription remains however to be characterized. We do
not know if mTor directly phosphorylates the insulin-
targeted transcription factors, or if its action is mediated by
a downstream kinase like the p70-S6kinase. Amino acids
analysis of SREBP-1 and NF-Y revealed the presence of
putative mTOR and p70-S6kinase phosphorylation sites
(Xue et al. 2005). In addition, these putative phosphoryla-
tion sites appear to be conserved in both human and
chicken transcription factors (data not shown). mTor may
also regulate the transcription of SCD1 by modulating the
level of expression of various transcription factors. In fact,
a microarray analysis showed that in cells treated with
rapamycin, SREBP-1 gene expression was inhibited (Peng
et al. 2002 60). This hypothesis remains however to be
demonstrated and is currently under investigation.
In conclusion, in hepatocytes, insulin regulates SCD1
gene expression by activating its level of transcription and
possibly by modulating the mRNA stability. Insulin
partially mediates its action acting on at least two different
IREs. The most 3′ IRE is localized between −372 and
−297 bp and binds both SREBP-1 and NF-Y transcription
factors in response to insulin. Insulin regulation of SCD1
gene transcription is mediated by activation of a PI3-kinase
and mTOR dependent signaling pathway targeting the two
different IREs. Taken together, our present findings builds
the link between the SCD1 gene expression and an insulin-
stimulated signaling pathway both implicated in the
development of several metabolic diseases such as obesity.
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